Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Rallybio sets one-for-two reverse split ahead of planned merger with Avenzo (RLYB:NASDAQ)

Summary by Seeking Alpha
Rallybio will complete a 1-for-2 reverse stock split ahead of its Avenzo Therapeutics merger, reducing shares from about 5.6 million to 2.8 million.

1 Articles

Seeking AlphaSeeking Alpha
Lean Right

Rallybio sets one-for-two reverse split ahead of planned merger with Avenzo (RLYB:NASDAQ)

Rallybio will complete a 1-for-2 reverse stock split ahead of its Avenzo Therapeutics merger, reducing shares from about 5.6 million to 2.8 million.

·Ra'anana, Israel
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Tuesday, November 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

New Haven, Connecticut icon

New Haven, Connecticut

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal